Mitchell Sinkler & Starr Organon & Co. Transaction History

Mitchell Sinkler & Starr

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $140,535 - $172,489	6,029 New	6,029 $168,000
Q2 2022 Jul 21, 2022	SELL	$31.66 - $38.9 $13,835 - $16,999	-437 Reduced 6.21%	6,601 $223,000
Q1 2022 Apr 19, 2022	SELL	$30.45 - $39.36 $2,283 - $2,952	-75 Reduced 1.05%	7,038 $246,000
Q4 2021 Feb 01, 2022	BUY	$28.67 - $37.13 $203,929 - $264,105	7,113 New	7,113 $217,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.79B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

Stay updated on Mitchell Sinkler & Starr with notifications on news.